SEC Form 4 · accession 0001225208-18-008934
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard R. DeLuca
Officer — EVP&Pres, Merck Animal Health
Period of report
May 4, 2018
Accepted (ET)
May 8, 2018 · 5:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 55,862 | D | ||
| Common Stock - 401(k) PlanF2 | holding | — | — | — | 1,048 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $57.75 | May 4, 2018 | A | 73,191 | A | May 4, 2019 | May 3, 2028 | Common Stock | 73,191 | 73,191 | D |
Explanation of responses
- F1Holdings include shares acquired in dividend reinvestment transactions.
- F2Includes shares acquired and dividends earned through April 6, 2018, in the Merck U.S. Savings Plan, a 401(k) plan.
- F3The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.